BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27626099)

  • 21. An important amino acid in nucleoprotein contributes to influenza A virus replication by interacting with polymerase PB2.
    Gui X; Li R; Zhang X; Shen C; Yu H; Guo X; Kang Y; Chen J; Chen H; Chen Y; Xia N
    Virology; 2014 Sep; 464-465():11-20. PubMed ID: 25043584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential virulence determinants associated H9N2 avian influenza virus PB2 E627K mutation by comparative proteomics.
    Qi W; Tian J; Su S; Huang L; Li H; Liao M
    Proteomics; 2015 May; 15(9):1512-24. PubMed ID: 25641917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir.
    Patel MC; Chesnokov A; Jones J; Mishin VP; De La Cruz JA; Nguyen HT; Zanders N; Wentworth DE; Davis TC; Gubareva LV
    Antiviral Res; 2021 Apr; 188():105035. PubMed ID: 33581212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.
    Singh KhD; Kirubakaran P; Nagamani S; Karthikeyan M
    Int J Comput Biol Drug Des; 2015; 8(1):1-18. PubMed ID: 25869316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses.
    Xiao C; Ma W; Sun N; Huang L; Li Y; Zeng Z; Wen Y; Zhang Z; Li H; Li Q; Yu Y; Zheng Y; Liu S; Hu P; Zhang X; Ning Z; Qi W; Liao M
    Sci Rep; 2016 Jan; 6():19474. PubMed ID: 26782141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.
    Jiang H; Xu Y; Li L; Weng L; Wang Q; Zhang S; Jia B; Hu H; He Y; Jacob Y; Toyoda T
    Antivir Chem Chemother; 2011 Nov; 22(3):119-30. PubMed ID: 22095520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus.
    Liu Y; Qin K; Meng G; Zhang J; Zhou J; Zhao G; Luo M; Zheng X
    J Biol Chem; 2013 Apr; 288(16):11013-23. PubMed ID: 23436652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single mutation at the amino acid position 627 of PB2 that leads to increased virulence of an H5N1 avian influenza virus during adaptation in mice can be compensated by multiple mutations at other sites of PB2.
    Li J; Ishaq M; Prudence M; Xi X; Hu T; Liu Q; Guo D
    Virus Res; 2009 Sep; 144(1-2):123-9. PubMed ID: 19393699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
    Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 mice.
    DesRochers BL; Chen RE; Gounder AP; Pinto AK; Bricker T; Linton CN; Rogers CD; Williams GD; Webby RJ; Boon AC
    Virology; 2016 Jul; 494():89-99. PubMed ID: 27105450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
    Hatakeyama D
    Yakugaku Zasshi; 2017; 137(2):205-214. PubMed ID: 28154333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The N terminus of PA polymerase of swine-origin influenza virus H1N1 determines its compatibility with PB2 and PB1 subunits through a strain-specific amino acid serine 186.
    Wanitchang A; Jengarn J; Jongkaewwattana A
    Virus Res; 2011 Jan; 155(1):325-33. PubMed ID: 21056603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free energy calculations and binding analysis of two potential anti- influenza drugs with Polymerase basic protein-2 (PB2).
    Lv HM; Guo XL; Gu RX; Wei DQ
    Protein Pept Lett; 2011 Oct; 18(10):1002-9. PubMed ID: 21592080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
    Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
    J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins.
    Patel D; Schultz LW; Umland TC
    Virus Res; 2013 Mar; 172(1-2):75-80. PubMed ID: 23246644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Avian Influenza A Virus Replication in Human Cells by Host Restriction Factor TUFM Is Correlated with Autophagy.
    Kuo SM; Chen CJ; Chang SC; Liu TJ; Chen YH; Huang SY; Shih SR
    mBio; 2017 Jun; 8(3):. PubMed ID: 28611246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses.
    Fu Y; Gaelings L; Söderholm S; Belanov S; Nandania J; Nyman TA; Matikainen S; Anders S; Velagapudi V; Kainov DE
    Antiviral Res; 2016 Sep; 133():23-31. PubMed ID: 27451344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Codon usage characteristics of PB2 gene in influenza A H7N9 virus from different host species.
    Gun L; Haixian P; Yumiao R; Han T; Jingqi L; Liguang Z
    Infect Genet Evol; 2018 Nov; 65():430-435. PubMed ID: 30179716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
    Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
    Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.